Acne is a common disease—it affects about 85 percent of us—and one of the most misunderstood, says Richard Antaya, MD, director of pediatric dermatology at Yale Medicine. It emerges in tandem with the ...

In the Phase 3 open-label extension clinical trial (OLE), patients with moderate to severe acne received denifanstat for up ...

Sagimet Biosciences (NASDAQ:SGMT) said its licensed partner Ascletis reported positive 52-week results from an open-label ...

Significant imbalances in sex hormones and oxidative stress were seen among women with severe acne vulgaris when compared with healthy controls.

I have been battling skin issues since I was in middle school, and even now as a working adult. When I was a student, my acne ...

Sagimet Biosciences Inc Series A (NASDAQ:SGMT) shares rose more than 12% in pre-market trading on Wednesday following the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — A rapid improvement in severe acne was observed in patients treated with 12 weeks of trifarotene and ...

(SGMT) reported positive 52-week results from its license partner Ascletis BioScience's Phase 3 open-label extension study of denifanstat in patients with moderate to severe acne vulgaris. The data ...

Acne vulgaris Researchers examined the relationship between dairy and acne severity and frequency. A significantly lower frequency of acne, as well as lower rates of severe acne, has been reported ...

Zoe Morgan, 25, is a Montreal-based content creator who shares videos about her "acne journey" and the realities of severe acne on social media "I no longer knew who I was anymore," the former pageant ...